{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:30:00Z","timestamp":1723177800584},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology","award":["15H01563","16K09724","26461314","22390181","25293206","15H05881"],"award-info":[{"award-number":["15H01563","16K09724","26461314","22390181","25293206","15H05881"]}]},{"DOI":"10.13039\/501100008667","name":"the SENSHIN Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Mitsubishi Tanabe Pharma Corporation"},{"name":"the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan"},{"DOI":"10.13039\/100008732","name":"the Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Novartis Foundation (Japan) for the Promotion of Science"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0881-7","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:59:03Z","timestamp":1494863943000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation"],"prefix":"10.1186","volume":"17","author":[{"given":"Masahiko","family":"Fukatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenobu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohkawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shichishima-Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"issue":"10","key":"881_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336.","journal-title":"Lancet Neurol."},{"issue":"5","key":"881_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12185-015-1785-1","volume":"101","author":"MO Jamil","year":"2015","unstructured":"Jamil MO, Mineishi S. State-of-the-art acute and chronic GVHD treatment. Int J Hematol. 2015;101(5):452\u201366.","journal-title":"Int J Hematol"},{"issue":"3","key":"881_CR3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","volume":"114","author":"AC Vigorito","year":"2009","unstructured":"Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP, Fero ML, Warren EH, Lee SJ, Appelbaum FR, et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood. 2009;114(3):702\u20138.","journal-title":"Blood"},{"issue":"3","key":"881_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389\u2013401. e381","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"881_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12185-011-0976-7","volume":"95","author":"AM Ngoma","year":"2012","unstructured":"Ngoma AM, Ikeda K, Hashimoto Y, Mochizuki K, Takahashi H, Sano H, Matsumoto H, Noji H, Saito S, Kikuta A, et al. Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int J Hematol. 2012;95(1):86\u201394.","journal-title":"Int J Hematol"},{"issue":"9","key":"881_CR6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.leukres.2010.03.017","volume":"34","author":"Q Li","year":"2010","unstructured":"Li Q, Zhai Z, Xu X, Shen Y, Zhang A, Sun Z, Liu H, Geng L, Wang Y. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res. 2010;34(9):1158\u201368.","journal-title":"Leuk Res"},{"key":"881_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40659-015-0033-8","volume":"48","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Ikeda K, Ogawa K, Saito S, Ngoma AM, Mashimo Y, Ueda K, Furukawa M, Shichishima-Nakamura A, Ohkawara H, et al. CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations. Biol Res. 2015;48:41.","journal-title":"Biol Res"},{"issue":"10","key":"881_CR8","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","volume":"133","author":"O Grauer","year":"2010","unstructured":"Grauer O, Wolff D, Bertz H, Greinix H, Kuhl JS, Lawitschka A, Lee SJ, Pavletic SZ, Holler E, Kleiter I. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease. Brain. 2010;133(10):2852\u201365.","journal-title":"Brain"},{"issue":"2","key":"881_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1701297","volume":"22","author":"F Baron","year":"1998","unstructured":"Baron F, Sadzot B, Wang F, Beguin Y. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998;22(2):197\u2013200.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"881_CR10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/WNL.36.8.1087","volume":"36","author":"GB Bolger","year":"1986","unstructured":"Bolger GB, Sullivan KM, Spence AM, Appelbaum FR, Johnston R, Sanders JE, Deeg HJ, Witherspoon RP, Doney KC, Nims J, et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology. 1986;36(8):1087\u201391.","journal-title":"Neurology"},{"issue":"2","key":"881_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0733-8619(18)30877-6","volume":"6","author":"KR Nelson","year":"1988","unstructured":"Nelson KR, McQuillen MP. Neurologic complications of graft-versus-host disease. Neurol Clin. 1988;6(2):389\u2013403.","journal-title":"Neurol Clin"},{"issue":"12","key":"881_CR12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bmt.1702067","volume":"24","author":"JE Dowell","year":"1999","unstructured":"Dowell JE, Moots PL, Stein RS. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplant. 1999;24(12):1359\u201361.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"881_CR13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1700759","volume":"19","author":"JR Mackey","year":"1997","unstructured":"Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant. 1997;19(9):939\u201342.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"881_CR14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000116395","volume":"29","author":"CI Smith","year":"1989","unstructured":"Smith CI, Norberg R, Moller G, Lonnqvist B, Hammarstrom L. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and gm markers. Eur Neurol. 1989;29(3):128\u201334.","journal-title":"Eur Neurol"},{"issue":"5","key":"881_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1704608","volume":"34","author":"C Hon","year":"2004","unstructured":"Hon C, Mak W, Kwok AK, Au WY. Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantation. Bone Marrow Transplant. 2004;34(5):455\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"881_CR16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mus.21023","volume":"38","author":"N Atassi","year":"2008","unstructured":"Atassi N, Amato AA. Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation. Muscle Nerve. 2008;38(2):1074\u20135.","journal-title":"Muscle Nerve"},{"issue":"7","key":"881_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"881_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","volume":"11","author":"K Wing","year":"2010","unstructured":"Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010;11(1):7\u201313.","journal-title":"Nat Immunol"},{"issue":"10","key":"881_CR19","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2007-05-091074","volume":"110","author":"X Chen","year":"2007","unstructured":"Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood. 2007;110(10):3804\u201313.","journal-title":"Blood"},{"issue":"1","key":"881_CR20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","volume":"116","author":"A Fattorossi","year":"2005","unstructured":"Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology. 2005;116(1):134\u201341.","journal-title":"Immunology"},{"issue":"2","key":"881_CR21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","volume":"105","author":"A Balandina","year":"2005","unstructured":"Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood. 2005;105(2):735\u201341.","journal-title":"Blood"},{"key":"881_CR22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2012.06844.x","volume":"1274","author":"MC Souroujon","year":"2012","unstructured":"Souroujon MC, Aricha R, Feferman T, Mizrachi K, Reuveni D, Fuchs S. Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis. Ann N Y Acad Sci. 2012;1274:120\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"881_CR23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","volume":"1274","author":"M Thiruppathi","year":"2012","unstructured":"Thiruppathi M, Rowin J, Li Jiang Q, Sheng JR, Prabhakar BS, Meriggioli MN. Functional defect in regulatory T cells in myasthenia gravis. Ann N Y Acad Sci. 2012;1274:68\u201376.","journal-title":"Ann N Y Acad Sci"},{"key":"881_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2015.03.008","volume":"281","author":"M Alahgholi-Hajibehzad","year":"2015","unstructured":"Alahgholi-Hajibehzad M, Oflazer P, Aysal F, Durmus H, Gulsen-Parman Y, Marx A, Deymeer F, Saruhan-Direskeneli G. Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity. J Neuroimmunol. 2015;281:51\u201360.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"881_CR25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/acn3.314","volume":"3","author":"D Anderson","year":"2016","unstructured":"Anderson D, Phan C, Johnston WS, Siddiqi ZA. Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up. Ann Clin Transl Neurol. 2016;3(7):552\u20135.","journal-title":"Ann Clin Transl Neurol."},{"issue":"4","key":"881_CR26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mus.24724","volume":"52","author":"KM Ruzhansky","year":"2015","unstructured":"Ruzhansky KM, Brannagan TH 3rd. Neuromuscular complications of hematopoietic stem cell transplantation. Muscle Nerve. 2015;52(4):480\u20137.","journal-title":"Muscle Nerve"},{"issue":"3","key":"881_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1705725","volume":"40","author":"F Zaja","year":"2007","unstructured":"Zaja F, Bacigalupo A, Patriarca F, Stanzani M, Van Lint MT, Fili C, Scime R, Milone G, Falda M, Vener C, et al. Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant. 2007;40(3):273\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"881_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10(4):236\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"881_CR29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.24799","volume":"61","author":"S Unal","year":"2014","unstructured":"Unal S, Sag E, Kuskonmaz B, Kesici S, Bayrakci B, Ayvaz DC, Tezcan I, Yalnizoglu D, Uckan D. Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatr Blood Cancer. 2014;61(5):928\u201330.","journal-title":"Pediatr Blood Cancer"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:12:09Z","timestamp":1589753529000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0881-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0881-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"article-number":"93"}}